Overview

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

Status:
COMPLETED
Trial end date:
2025-10-10
Target enrollment:
Participant gender:
Summary
This study evaluated the preemptive analgesic efficacy of Tapentadol in reducing peri operative analgesic requirements among patients undergoing breast cancer surgery.
Phase:
NA
Details
Lead Sponsor:
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Treatments:
Tapentadol